Product NDC: | 0615-1341 |
Proprietary Name: | Diltiazem Hydrochloride |
Non Proprietary Name: | Diltiazem Hydrochloride |
Active Ingredient(s): | 180 mg/1 & nbsp; Diltiazem Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0615-1341 |
Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074984 |
Marketing Category: | ANDA |
Start Marketing Date: | 19991220 |
Package NDC: | 0615-1341-31 |
Package Description: | 31 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0615-1341-31) |
NDC Code | 0615-1341-31 |
Proprietary Name | Diltiazem Hydrochloride |
Package Description | 31 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0615-1341-31) |
Product NDC | 0615-1341 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diltiazem Hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19991220 |
Marketing Category Name | ANDA |
Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Strength Number | 180 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |